United Therapeutics | UTHR - Capital De Préstamo





Capital De Préstamo Cambio Fecha
Ardelyx USD 203.52M 683K 2026-03
Baxter International USD 8.62B 6M 2026-06
Bayer EUR 30.68B 1.15B 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Insmed USD 542.22M 1.25M 2026-03
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
J&J USD 37.34B 183M 2026-06
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Moderna USD 597M 6M 2026-06
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12